CDC34 antibody (Middle Region)
Quick Overview for CDC34 antibody (Middle Region) (ABIN926912)
Target
See all CDC34 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Cross-Reactivity
- Mouse (Murine), Rat (Rattus)
-
Purification
- Purified
-
Immunogen
- CDC34 antibody was raised in rabbit using the middle region of CDC34 as the immunogen
-
-
-
-
Application Notes
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
CDC34 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CDC34 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDC34 (Cell Division Cycle 34 (CDC34))
-
Alternative Name
- CDC34
-
Background
- CDC34 catalyzes the covalent attachment of ubiquitin to other proteins. CDC34 may be involved in degradation of katenin.The protein encoded by this gene is a member of the ubiquitin-conjugating enzyme family. Ubiquitin-conjugating enzyme catalyzes the covalent attachment of ubiquitin to other proteins. This protein is a part of the large multiprotein complex, which is required for ubiquitin-mediated degradation of cell cycle G1 regulators, and for the initiation of DNA replication. Synonyms: Polyclonal CDC34 antibody, Anti-CDC34 antibody, cell division cycle 34 homolog, S. cerevisiae antibody, E2-CDC34 antibody, UBC3 antibody, UBE2R1 antibody.
Target
-